1199 Determining the Underlying Mechanisms of Glioma Progression and Recurrence
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: Despite recent advances in the molecular characterization of gliomas, there remains a need to better understand tumor progression through biomarkers and predictors of recurrence that can be leveraged as potential future therapeutic targets. METHODS: We generated a cohort of 271 gliomas from 176 patients including a unique cohort of 81 patients with paired primary (pre-treatment) and recurrent (post-treatment) tumors using a comprehensive integrated multi-platform analysis consisting of DNA methylation, proteomics, and gene expression data, with 10-year follow-up data. RESULTS: Recurrent IDH mutant gliomas exhibited a global loss of methylation at recurrence, specifically those that undergo malignant transformation to higher grade tumors at recurrence. The transcription family ATF is associated with malignant transformation, and NFATC1 is a biomarker of poor prognosis. Both PABN1L and NOTUM are plasma biomarkers of progression that can be measured longitudinally to monitor risk of recurrence and progression non-invasively. In IDH wildtype GBM, we identified and characterized a novel subgroup associated with longer survival, decreased immune and mesenchymal infiltration, and global increase in methylation. We identified and validated two novel biomarkers, PDE9A and RASA4, associated with this subgroup and prolonged survival. CONCLUSIONS: In summary, we have defined a comprehensive, multi-platform analysis of paired gliomas that has led to the identification of novel subgroups of recurrent disease, new clinically applicable biomarkers for disease progression, and a resource for future studies.
Fields of Study & Subjects
Glioma Diagnosis and Treatment
Acute Myeloid Leukemia Research
Cancer Genomics and Diagnostics
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 234–234
- Publication date
- 26 March 2026
- Language
- EN